Grundsätze nachhaltiger Unternehmensführung: Erfolg durch verantwortungsvolles Management von Günther, Edeltraud, Buhlmann, Hans-Martin, Czernin, Felix

Volltext

Effects of Recovery-Orientation on the Use of Forced Medication and Maximum Daily Drug Dose: The "Weddinger Modell" von Czernin, Klara, Bermpohl, Felix, Wullschleger, Alexandre, Mahler, Lieselotte

Volltext

False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial von Fendler, Wolfgang P., Calais, Jeremie, Eiber, Matthias, Simko, Jeffrey P., Kurhanewicz, John, Santos, Romelyn Delos, Feng, Felix Y., Reiter, Robert E., Rettig, Matthew B., Nickols, Nicholas G., Kishan, Amar U., Slavik, Roger, Carroll, Peter R., Lawhn-Heath, Courtney, Herrmann, Ken, Czernin, Johannes, Hope, Thomas A.

Volltext

Correlates of seclusion and restraint of patients admitted to psychiatric inpatient treatment via a German emergency room von Cole, Celline, Vandamme, Angelika, Bermpohl, Felix, Czernin, Klara, Wullschleger, Alexandre, Mahler, Lieselotte

Volltext

A Pilot Study of Immunological Response to PSMA-Directed Radioligand Therapy for the Treatment of Oligometastatic Prostate Cancer von Valle, L., James-Allan, L.B., Franco, A., Felix, C., Rietdorf, E., Czernin, J., Steinberg, M.L., Nickols, N.G., Rettig, M., Weidhaas, J.B., Calais, J., Kishan, A.U.

Volltext

LUNAR: a randomized Phase 2 study of 177Lutetium‐PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol) von Ma, Ting Martin, Czernin, Johannes, Felix, Carol, Alano, Rejah, Wilhalme, Holly, Valle, Luca, Steinberg, Michael L., Dahlbom, Magnus, Reiter, Robert E., Rettig, Matthew B., Cao, Minsong, Calais, Jeremie, Kishan, Amar U.

Volltext

LUNAR: a randomized Phase 2 study of 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol) von Ma, Ting Martin, Czernin, Johannes, Felix, Carol, Alano, Rejah, Wilhalme, Holly, Valle, Luca, Steinberg, Michael L, Dahlbom, Magnus, Reiter, Robert E, Rettig, Matthew B, Cao, Minsong, Calais, Jeremie, Kishan, Amar U

Volltext

Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial von Fendler, Wolfgang, Ferdinandus, Justin, Calais, Jeremie, Eiber, Matthias, Flavell, Robert R., Mishoe, Ashley, Feng, Felix Y, Nguyen, Hao Gia, Reiter, Robert Evan, Rettig, Matthew, Gartmann, Jeannine, Smith, Raven, Small, Eric Jay, Slavik, Roger, Carroll, Peter, Herrmann, Ken, Czernin, Johannes, Hope, Thomas

Volltext

False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial von Fendler, Wolfgang P, Calais, Jeremie, Eiber, Matthias, Simko, Jeffrey P, Kurhanewicz, John, Santos, Romelyn Delos, Feng, Felix Y, Reiter, Robert E, Rettig, Matthew B, Nickols, Nicholas G, Kishan, Amar U, PSMA PET Reader Group, Slavik, Roger, Carroll, Peter R, Lawhn-Heath, Courtney, Herrmann, Ken, Czernin, Johannes, Hope, Thomas A

Volltext

EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT) von Kratochwil, Clemens, Fendler, Wolfgang Peter, Eiber, Matthias, Baum, Richard, Bozkurt, Murat Fani, Czernin, Johannes, Delgado Bolton, Roberto C., Ezziddin, Samer, Forrer, Flavio, Hicks, Rodney J., Hope, Thomas A., Kabasakal, Levant, Konijnenberg, Mark, Kopka, Klaus, Lassmann, Michael, Mottaghy, Felix M., Oyen, Wim, Rahbar, Kambiz, Schöder, Heiko, Virgolini, Irene, Wester, Hans-Jürgen, Bodei, Lisa, Fanti, Stefano, Haberkorn, Uwe, Herrmann, Ken

Volltext

Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Pro... von Ma, Ting Martin, Gafita, Andrei, Shabsovich, David, Juarez, Jesus, Grogan, Tristan R., Thin, Pan, Armstrong, Wesley, Sonni, Ida, Nguyen, Kathleen, Lok, Vincent, Reiter, Robert E., Rettig, Matthew B., Steinberg, Michael L., Kupelian, Patrick A., Yang, David D., Muralidhar, Vinayak, Chu, Carissa, Feng, Felix, Savjani, Ricky, Deng, Jie, Parikh, Neil R., Nickols, Nicholas G., Elashoff, David, Czernin, Johannes, Calais, Jeremie, Kishan, Amar U.

Volltext

Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial von Fendler, Wolfgang P, Calais, Jeremie, Eiber, Matthias, Flavell, Robert R, Mishoe, Ashley, Feng, Felix Y, Nguyen, Hao G, Reiter, Robert E, Rettig, Matthew B, Okamoto, Shozo, Emmett, Louise, Zacho, Helle D, Ilhan, Harun, Wetter, Axel, Rischpler, Christoph, Schoder, Heiko, Burger, Irene A, Gartmann, Jeannine, Smith, Raven, Small, Eric J, Slavik, Roger, Carroll, Peter R, Herrmann, Ken, Czernin, Johannes, Hope, Thomas A

Volltext

EANM procedure guidelines for radionuclide therapy with 177 Lu-labelled PSMA-ligands ( 177 Lu-PSMA-RLT) von Kratochwil, Clemens, Fendler, Wolfgang Peter, Eiber, Matthias, Baum, Richard, Bozkurt, Murat Fani, Czernin, Johannes, Delgado Bolton, Roberto C, Ezziddin, Samer, Forrer, Flavio, Hicks, Rodney J, Hope, Thomas A, Kabasakal, Levant, Konijnenberg, Mark, Kopka, Klaus, Lassmann, Michael, Mottaghy, Felix M, Oyen, Wim, Rahbar, Kambiz, Schöder, Heiko, Virgolini, Irene, Wester, Hans-Jürgen, Bodei, Lisa, Fanti, Stefano, Haberkorn, Uwe, Herrmann, Ken

Volltext